All Stories

  1. Integrating Host Genetics and Clinical Setting in Machine Learning Models: Predicting COVID-19 Prognosis for Healthcare Decision-Making (The FeMiNa Study)
  2. SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile
  3. Myeloperoxidase (MPO) Enzymatic Activity, but Not Its Protein Concentration, Is Associated with the Risk of Type 2 Diabetes in Females, Regardless of Obesity Status
  4. Safety and Efficacy of Noninvasive Ventilation in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease and Decreased Level of Consciousness: A Retrospective Study
  5. Palmitic acid differently modulates extracellular vesicles and cellular fatty acid composition of SGBS adipocytes without impairing their insulin signaling
  6. Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women
  7. Gut microbiota dysbiosis and its relation to osteoporosis and sarcopenia in older people
  8. Breast Cancer Cell Line-Specific Responses to Insulin: Effects on Proliferation and Migration
  9. Advanced glycation end-product intake predicts insulin resistance in a sex-dependent fashion
  10. HOMA-IR and TyG index differ for their relationship with dietary, anthropometric, inflammatory factors and capacity to predict cardiovascular risk
  11. Increase of VEGF and Fibronectin expression and ultrastructural alterations of intercellular junctions in a swab negative patient after SARS-COV-2 infection
  12. Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group
  13. Serum β-secretase 1 (sBACE1) activity in subjective cognitive decline: an exploratory study
  14. The influence of prolonged aerobic exercise on cardiac, muscular, and renal biomarkers in trained individuals with obesity
  15. A case report of a probable drug-induced liver injury after therapy remodulation with lamotrigine, quetiapine and sertraline in an adult female with recurrent major depression using the updated RUCAM score
  16. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
  17. Bioaccumulation Rate of Non-Biodegradable Polystyrene Microplastics in Human Epithelial Cell Lines
  18. Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae
  19. Ex vivo propofol permeation across nasal mucosa: A proof-of-concept study for outpatient light sedation via nasal route
  20. Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues
  21. Ceramides as Emerging Players in Cardiovascular Disease: Focus on Their Pathogenetic Effects and Regulation by Diet
  22. The complex interplay between oxinflammation, mitochondrial dysfunction and lipotoxicity: Focus on their role in the pathogenesis of skeletal muscle insulin resistance and modulation by dietary fatty acids
  23. HDL-Cholesterol Subfraction Dimensional Distribution Is Associated with Cardiovascular Disease Risk and Is Predicted by Visceral Adiposity and Dietary Lipid Intake in Women
  24. Dyslipidemia, Cholangitis and Fatty Liver Disease: The Close Underexplored Relationship: A Narrative Review
  25. Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study
  26. Predicting in-hospital mortality in patients with acute pancreatitis in the ED: a direct, retrospective comparison of four clinical and radiological prognostic scores
  27. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
  28. The role of echocardiography in pulmonary embolism for the prediction of in-hospital mortality: a retrospective study
  29. Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry
  30. In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies
  31. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
  32. Diagnostic accuracy of Point Of Care UltraSound (POCUS) in clinical practice: A retrospective, emergency department based study
  33. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
  34. Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Obs...
  35. Predicting in‐hospital mortality in patients admitted from the emergency department for pulmonary embolism: Incidence and prognostic value of deep vein thrombosis. A retrospective study
  36. A case of hemorrhagic shock due to massive upper gastrointestinal bleeding: from the differential diagnosis to the correct management
  37. The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study
  38. Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group
  39. Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case–control study
  40. Sarcopenia parameters in active older adults – an eight-year longitudinal study
  41. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
  42. Case report: Tissue positivity for SARS-CoV-2 in a preterm born infant death of thrombosis: possible intrauterine transmission
  43. The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
  44. Interleukin-18 Is a Potential Biomarker Linking Dietary Fatty Acid Quality and Insulin Resistance: Results from a Cross-Sectional Study in Northern Italy
  45. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
  46. A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease
  47. Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance
  48. Rapid Assessment of COVID-19 Mortality Risk with GASS Classifiers
  49. Effect of SARS-CoV-2 infection in pregnancy on CD147, ACE2 and HLA-G expression
  50. Kinetic of Non-Biodegradable Polystyrene Microplastics: How Different Human Epithelial Cells Behave in Terms of Internalization and Clearance of Microplastic Particles
  51. Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial
  52. Inquadramento diagnostico del paziente con possibile ipercolesterolemia familiare omozigote: il parere di un gruppo italiano di esperti
  53. Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
  54. Predicting in-hospital mortality in pulmonary embolism patients: development and external validation of PATHOS score
  55. Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease
  56. Skeletal Muscle Mitochondrial and Perilipin Content in a Cohort of Obese Subjects Undergoing Moderate and High Intensity Training
  57. ABCD2, ABCD2-I, and OTTAWA scores for stroke risk assessment: a direct retrospective comparison
  58. Irisin Attenuates Muscle Impairment during Bed Rest through Muscle-Adipose Tissue Crosstalk
  59. The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
  60. Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group
  61. P342 REAL–WORLD ANALYSIS ON THE ECONOMIC VALUE OF REACHING LIPID TARGET IN ITALY
  62. P357 THE MANAGEMENT OF CHOLESTEROL LEVEL CONTROL WITH LIPID–LOWERING DRUGS IN ITALIAN CLINICAL PRACTICE: FINDINGS FROM THE STREAM (SUPPORTING WITH THE REAL–WORLD EVIDENCE THE ASSESSMENT OF MEDICINES AND HEALTH TECHNOLOGIES) STUDY
  63. P358 THE ROLE OF ADHERENCE TO LIPID–LOWERING THERAPIES IN ACHIEVING LIPID TARGET: FINDINGS FROM REAL–WORLD ANALYSIS IN ITALY
  64. Dietary Acid Load but Not Mediterranean Diet Adherence Score Is Associated With Metabolic and Cardiovascular Health State: A Population Observational Study From Northern Italy
  65. Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
  66. Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project
  67. Biological Response of Irisin Induced by Different Types of Exercise in Obese Subjects: A Non-Inferiority Controlled Randomized Study
  68. Physical capacities and leisure activities are related with cognitive functions in older adults
  69. COVID-19 induced aorto duodenal fistula following evar in the so called “negative” patient
  70. Rapid assessment of COVID-19 mortality risk with GASS classifiers
  71. Rethinking of osteoporosis through a sex- and gender-informed approach in the COVID-19 era
  72. Relevance of VEGF and CD147 in different SARS‐CoV‐2 positive digestive tracts characterized by thrombotic damage
  73. Dementia and in-hospital mortality: retrospective analysis of a nationwide administrative database of elderly subjects in Italy
  74. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
  75. Bowel ischemia as onset of COVID‐19 in otherwise asymptomatic patients with persistently negative swab
  76. COVID-19 and Blood Groups: A Six-Months Observational Study in Ferrara, Italy
  77. COVID-19 inpatients with gastrointestinal onset: sex and care needs’ differences in the district of Ferrara, Italy
  78. Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia
  79. Early Prediction of COVID-19 Outcome: Contrasting Clinical Scores and Computational Intelligence Methods
  80. Effectiveness of high-intensity interval training for weight loss in adults with obesity: a randomised controlled non-inferiority trial
  81. Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis
  82. Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
  83. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient
  84. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study
  85. Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
  86. Risk of dementia in patients with atrial fibrillation: Short versus long follow‐up. A systematic review and meta‐analysis
  87. Role of Statins in Coronavirus-Related Disease (COVID-19): A Retrospective Cohort Study in Northern Italy
  88. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
  89. High intensity interval training is effective as endurance training in lipid profile management: A randomized controlled trial comparing different aerobic exercises in obese people
  90. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients
  91. Clinical and demographic parameters predict the progression from mild cognitive impairment to dementia in elderly patients
  92. Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease
  93. Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
  94. Effects of 3-month high-intensity interval training vs. moderate endurance training and 4-month follow-up on fat metabolism, cardiorespiratory function and mitochondrial respiration in obese adults
  95. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease
  96. Association of Hypomorphic P2X7 Receptor Genotype With Age
  97. Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease
  98. Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation
  99. Il-18 As A Possible Link Between Physical Inactivity And Insulin Resistance
  100. Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage
  101. The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels
  102. Correlation of the endoscopic findings for small and large bowels in pediatric patients with established Crohn’s disease
  103. Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1
  104. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
  105. Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer’s Disease
  106. Gene expression profiling of gluteal adipose tissue after prolonged bedrest
  107. Gene expression of FNDC5 and related genes in gluteal subcutaneous adipose tissue and plasma irisin levels after acute inactivity
  108. TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
  109. Effects of 14 days of bed rest and following physical training on metabolic cost, mechanical work, and efficiency during walking in older and young healthy males
  110. PHYSICAL ACTIVITY AND EXERCISE AS A KEY FACTOR IN SUCCESSFUL AGING
  111. Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia
  112. Loss of maximal explosive power of lower limbs after 2 weeks of disuse and incomplete recovery after retraining in older adults
  113. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation
  114. Lower Plasma Klotho Concentrations Are Associated with Vascular Dementia but Not Late-Onset Alzheimer’s Disease
  115. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women
  116. Anabolic resistance assessed by oral stable isotope ingestion following bed rest in young and older adult volunteers: Relationships with changes in muscle mass
  117. Abstracts from the 2017 Italian-German Purine Club Meeting
  118. Dietary composition may influence Nesfatin-1 plasma concentration in humans
  119. Effect of 14 days of experimental horizontal bed rest on circulating levels of irisin
  120. Gene expression profiling of gluteal adipose tissue after prolonged bedrest
  121. Gene expression regional differences in human subcutaneous adipose tissue
  122. Obstructive Sleep Apnea syndrome in obese patients: Effects on metabolic and cardiovascular profile and impact of 6 months of behavioural therapy
  123. Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells
  124. CCT AND BDNF DURING BED REST: PROTECTING AGING INDIVIDUALS FROM ACUTE STRESS
  125. Gene expression regional differences in human subcutaneous adipose tissue
  126. Computerized cognitive training and brain derived neurotrophic factor during bed rest: mechanisms to protect individual during acute stress
  127. Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
  128. Gene expression profiling of gluteal adipose tissue after prolonged bedrest
  129. Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases
  130. Bilateral strio-pallido-dentate calcinosis (Fahr’s disease): report of seven cases and revision of literature
  131. Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
  132. Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
  133. Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals
  134. Age-related differences in plasma BDNF levels after prolonged bed rest
  135. Greater loss in muscle mass and function but smaller metabolic alterations in older compared with younger men following 2 wk of bed rest and recovery
  136. Exceptional Exercise Capacity in an 80-Year-Old Breast Cancer Survivor and Long-Term Sprint Athlete
  137. serum paraoxonase in alzheimer and MCI
  138. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
  139. Serum levels of hydroperoxides and multimorbidity among older patients with mild cognitive impairment or late-onset Alzheimer’s disease
  140. PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
  141. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)
  142. Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
  143. Effect of 14 days experimental horizontal bed rest on lipid and inflammatory profile
  144. Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
  145. Brain-Derived Neurotrophic Factor Plasma Levels: Relationship With Dementia and Diabetes in the Elderly Population
  146. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia
  147. Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol
  148. Is a liberal transfusion strategy better than a symptomatic strategy in patients with cardiovascular disease undergoing surgical hip fracture repair?
  149. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study
  150. PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome
  151. Session information
  152. Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals
  153. Reduced factor VII and factor VIII levels and prolonged thrombin-generation times during a healthy diet in middle-aged women with mild to moderate cardiovascular disease risk
  154. Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia
  155. MODERATE ALCOHOL INTAKE AND HEMOSTATIC AND INFLAMMATORY MARKERS IN MIDDLE-AGED WOMEN: A CONTROLLED STUDY
  156. PO5-136 ASSOCIATION BETWEEN ACE GENE INSERTION/DELETION (ACE I/D) POLYMORPHISM, PPAR-GAMMA PRO12ALA (PRO12ALA) POLYMORPHISM AND ATPIII METABOLIC SYNDROME COMPONENTS IN A COHORT OF OBESE SUBJECTS
  157. PO20-595 SHORT TERM EFFECT OF FOUR DIFFERENT MACRONUTRIENT ORAL LOADS ON METABOLIC PROFILE AND FLOW MEDIATED VASODILATATION IN HEALTHY YOUNG MEN
  158. Transient massive hyperlipidaemia in a type 2 diabetic subject
  159. Acute Vascular Events and Electrolytes Variations in Elderly Patients
  160. We-W33:3 Adiposity is an important determinant of chronic low-grade inflammation and is associated with carotid artery intima-media thickness
  161. Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes
  162. TRACE ELEMENTS AND COGNITIVE IMPAIRMENT: AN ELDERLY COHORT STUDY
  163. Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport
  164. Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up
  165. Abstracts of the IDF Congress in Paris 2003
  166. Metabolic Profile in Patients with Benign Prostate Hyperplasia or Prostate Cancer and Normal Glucose Tolerance
  167. Atorvastatin improves metabolic control and endothelial function in Type 2 diabetic patients: A placebo-controlled study
  168. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: A randomized, placebo-controlled clinical trial
  169. Abstracts of the 37th Annual Meeting of the EASD Glasgow, United Kingdom, 9–13 September 2001
  170. Role of diabetes in influencing leptin concentration in elderly overweight patients
  171. Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women
  172. A Defect in Glycogen Synthesis Characterizes Insulin Resistance in Hypertensive Patients With Type 2 Diabetes
  173. Benzodiazepines with different half-life and falling in a hospitalized population
  174. The relationship of plasma glucose and electrocardiographic parameters in elderly women with different degrees of glucose tolerance
  175. Simvastatin, transdermal patch and oral estrogen-progestin preparation in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial
  176. Effect of Native and Oxidized Low-Density Lipoprotein on Endothelial Nitric Oxide and Superoxide Production
  177. Factors influencing plasma homocysteine levels in type 2 diabetes
  178. 35th Annual Meeting of the European Association for the Study of Diabetes
  179. C41 Factors influencing plasma homocysteine as marker of CHD in type 2 diabetes
  180. MTHFR mutation and carotid wall thickness in aging non diabetic women
  181. Abstract
  182. 60 Effect of native low density lipoproteins on nitric oxide and superoxide production by endothelial cells